Clinical Trials Browser

Phase 1 × Recruiting × Non-Muscle Invasive Bladder Neoplasms × Clear all

NCT05483868 2026-04-15

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07206225 2026-04-07

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06173349 2026-03-13

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06351904 2025-09-11

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT05126472 2025-09-04

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT05519241 2025-09-02

A Phase I Intravesical PPM Therapy for NMIBC

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06186414 2025-01-15

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06632964 2024-10-09

A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

Phase 1 Recruiting

Non-Muscle Invasive Bladder Neoplasms